DESMOID FIBROMATOSIS
Clinical trials for DESMOID FIBROMATOSIS explained in plain language.
Never miss a new study
Get alerted when new DESMOID FIBROMATOSIS trials appear
Sign up with your email to follow new studies for DESMOID FIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on 50+ rare cancers in major trial
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) in over 800 people with more than 50 types of rare cancers. The goal is to see if this treatment can shrink tumors by helping the immune system attack cancer cells. The study is for patie…
Matched conditions: DESMOID FIBROMATOSIS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Promising pill may shrink rare tumors in kids without surgery
Disease control OngoingThis study tests a drug called nirogacestat in children and teens with desmoid tumors that have grown despite treatment and cannot be surgically removed. The goal is to see if the drug can stop or slow tumor growth and to check for side effects. About 31 participants aged 1 to 18…
Matched conditions: DESMOID FIBROMATOSIS
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 14, 2026 12:03 UTC